282 related articles for article (PubMed ID: 29203853)
1. Quantitative Analysis of Inflammation in Orbital Fat of Thyroid-associated Ophthalmopathy Using MRI Signal Intensity.
Higashiyama T; Iwasa M; Ohji M
Sci Rep; 2017 Dec; 7(1):16874. PubMed ID: 29203853
[TBL] [Abstract][Full Text] [Related]
2. Quantitative evaluation of activity of thyroid-associated Ophthalmopathy using short-tau inversion recovery (STIR) sequence.
Ge Q; Zhang X; Wang L; Fan Y; Huang Q; Yao N; Long J; Liu C
BMC Endocr Disord; 2021 Nov; 21(1):226. PubMed ID: 34774035
[TBL] [Abstract][Full Text] [Related]
3. Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy.
Higashiyama T; Nishida Y; Morino K; Ugi S; Nishio Y; Maegawa H; Ohji M
Jpn J Ophthalmol; 2015 Mar; 59(2):124-30. PubMed ID: 25448468
[TBL] [Abstract][Full Text] [Related]
4. [The value of DCE-MRI in assessing the course of thyroid associated ophthalmopathy].
Wu T; Tang DR; Wang F; Xia S; Sun FY
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):430-435. PubMed ID: 28606264
[No Abstract] [Full Text] [Related]
5. Correlation between extent of lacrimal gland prolapse and clinical features of thyroid-associated ophthalmopathy: a retrospective observational study.
Gao Y; Chang Q; Li Y; Zhang H; Hou Z; Zhang Z; Li Z; Li D
BMC Ophthalmol; 2022 Feb; 22(1):66. PubMed ID: 35144579
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of orbital soft tissues on computed tomography to assess the activity of thyroid-associated orbitopathy.
Byun JS; Moon NJ; Lee JK
Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):413-420. PubMed ID: 27838736
[TBL] [Abstract][Full Text] [Related]
7. Quantitative T1 mapping MRI for the assessment of extraocular muscle fibrosis in thyroid-associated ophthalmopathy.
Ma R; Geng Y; Gan L; Peng Z; Cheng J; Guo J; Qian J
Endocrine; 2022 Feb; 75(2):456-464. PubMed ID: 34549377
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of extraocular muscles in patients with thyroid associated ophthalmopathy using apparent diffusion coefficient measured by magnetic resonance imaging before and after radiation therapy.
Yu W; Zheng L; Shuo Z; Xingtong L; Mengda J; Lin Z; Ziyang S; Huifang Z
Acta Radiol; 2022 Sep; 63(9):1180-1186. PubMed ID: 34338029
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of the ratio of orbital fat to total orbit area in mild-to-moderate thyroid-associated ophthalmopathy.
Kim HC; Yoon SW; Lew H
Br J Radiol; 2015 Sep; 88(1053):20150164. PubMed ID: 26151616
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric magnetic resonance imaging for differentiating active from inactive thyroid-associated ophthalmopathy: Added value from magnetization transfer imaging.
Hu H; Chen L; Zhou J; Chen W; Chen HH; Zhang JL; Hsu YC; Xu XQ; Wu FY
Eur J Radiol; 2022 Jun; 151():110295. PubMed ID: 35405579
[TBL] [Abstract][Full Text] [Related]
11. ROLE OF MAGNETIC RESONANCE IMAGING IN THE ASSESSMENT OF ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY PATIENTS WITH LONG DISEASE DURATION.
Zhou M; Shen L; Jiao Q; Ye L; Zhou Y; Zhu W; Wang W; Wang S
Endocr Pract; 2019 Dec; 25(12):1268-1278. PubMed ID: 31412229
[No Abstract] [Full Text] [Related]
12. Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg.
Politi LS; Godi C; Cammarata G; Ambrosi A; Iadanza A; Lanzi R; Falini A; Bianchi Marzoli S
Eur Radiol; 2014 May; 24(5):1118-26. PubMed ID: 24519110
[TBL] [Abstract][Full Text] [Related]
13. [Short-tau inversion-recovery (STIR) sequence magnetic resonance imaging evaluation of orbital structures in Graves' orbitopathy].
Rodríguez-González N; Pérez-Rico C; López-Para Giménez R; Arévalo-Serrano J; Del Amo García B; Calzada Domingo L; Flores Ruiz L; Blanco R
Arch Soc Esp Oftalmol; 2011 Nov; 86(11):351-7. PubMed ID: 22040641
[TBL] [Abstract][Full Text] [Related]
14. [Calculation of orbital fat volumes for determining treatment timing for thyroid- associated ophthalmopathy].
Jiang W; Cai QY; Li ZF; Chen ZY; Luo YS; Hu SD; Shen J
Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):640-645. PubMed ID: 28539287
[TBL] [Abstract][Full Text] [Related]
15. [Clinical Analysis of 2 170 Cases of Thyroid-Associated Ophthalmopathy Involving Extraocular Muscles].
Yang M; Du BX; Wang YJ; He WM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):510-515. PubMed ID: 34018373
[TBL] [Abstract][Full Text] [Related]
16. Semi-automatic volume measurement for orbital fat and total extraocular muscles based on Cube FSE-flex sequence in patients with thyroid-associated ophthalmopathy.
Tang X; Liu H; Chen L; Wang Q; Luo B; Xiang N; He Y; Zhu W; Zhang J
Clin Radiol; 2018 Aug; 73(8):759.e11-759.e17. PubMed ID: 29804628
[TBL] [Abstract][Full Text] [Related]
17. Correlation of clinical and radiological scores for evaluation of activity in patients having thyroid-associated orbitopathy: A prospective observational study.
Singh M; Rana N; Ahuja C; Gupta P; Zadeng Z
Indian J Ophthalmol; 2024 Jun; 72(6):844-848. PubMed ID: 38804801
[TBL] [Abstract][Full Text] [Related]
18. T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study.
Das T; Roos JCP; Patterson AJ; Graves MJ; Murthy R
Eye (Lond); 2019 Feb; 33(2):235-243. PubMed ID: 30538310
[TBL] [Abstract][Full Text] [Related]
19. MRI measurements of orbital tissues in dysthyroid ophthalmopathy.
Nishida Y; Tian S; Isberg B; Tallstedt L; Lennerstrand G
Graefes Arch Clin Exp Ophthalmol; 2001 Nov; 239(11):824-31. PubMed ID: 11789862
[TBL] [Abstract][Full Text] [Related]
20. Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy.
Higashiyama T; Nishida Y; Ohji M
Clin Ophthalmol; 2016; 10():721-9. PubMed ID: 27143850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
